Supplementary Figure 2:
Dual combinations with luminespib and INK128 or ruxolitinib synergistically inhibit mutant STAT3 activity. HEK293-SIE reporter cells expressing mutant STAT3 were treated with increasing concentrations of the two compounds, incubated for 6 hours, and then the luciferase signal measured. The results are presented in 2-D plots with red color indicating drug synergism and green color antagonism. Synergism was calculated using the ZIP method and the additive score was calculated using the HSA method. The additive/synergistic area scores presented in the table were calculated from concentrations within the overlying squares in the 2-D plots. Results are shown as a drug sensitivity score (DSS), which were calculated from the dose response curves generated from the viability of the NK cell lines measured after 3-day incubation with the compounds using the CTG assay. 
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